Parisi Gray Wealth Management’s Biogen BIIB Stock Holding History

Parisi Gray Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-853	Closed	-$205K	–	123
2021 Q4	$205K	Hold	853	–	–	0.08%	123
2021 Q3	$242K	Sell	853 -60	-7%	-$19.7K	0.1%	111
2021 Q2	$316K	Hold	913	–	–	0.12%	107
2021 Q1	$255K	Hold	913	–	–	0.11%	110
2020 Q4	$224K	Hold	913	–	–	0.1%	111
2020 Q3	$259K	Hold	913	–	–	0.13%	99
2020 Q2	$244K	Hold	913	–	–	0.14%	97
2020 Q1	$289K	Sell	913 -13	-1%	-$3.94K	0.2%	81
2019 Q4	$275K	Sell	926 -6	-0.6%	-$1.67K	0.16%	86
2019 Q3	$217K	Sell	932 -20	-2%	-$4.66K	0.14%	95
2019 Q2	$223K	Sell	952 -18	-2%	-$4.16K	0.15%	93
2019 Q1	$229K	Sell	970 -500	-34%	-$157K	0.15%	90
2018 Q4	$431K	Hold	1,470	–	–	0.29%	68
2018 Q3	$523K	Hold	1,470	–	–	0.32%	72
2018 Q2	$525K	Buy	1,470 +335	+30%	+$94.2K	0.35%	69
2018 Q1	$302K	Sell	1,135 -14	-1%	-$4.35K	0.23%	83
2017 Q4	$384K	Buy	+1,149	New	+$369K	0.29%	77

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Parisi Gray Wealth Management's BIIB Position: Q1 2022 in Review

Parisi Gray Wealth Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 853 shares — an estimated $205K sold.

Parisi Gray Wealth Management first reported a position in BIIB in Q4 2017 and held it in 17 quarters. The position peaked at $525K in Q2 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Parisi Gray Wealth Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Parisi Gray Wealth Management sold 853 Biogen shares in Q1 2022, an estimated $205K.
Parisi Gray Wealth Management first reported a position in Biogen in Q4 2017 and held it in 17 quarters.
Parisi Gray Wealth Management's Biogen position peaked at $525K in Q2 2018.
951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Parisi Gray Wealth Management's 13F filing for Q1 2022, filed 13 May 2022.